Distinct Effects of Copper Ionophores on Intracellular Copper and Cell Viability in Wild-Type and CTR1-Deficient SH-SY5Y Cells
Open Access
- 10 August 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (33) , 49807-49814
Abstract
Copper homeostasis is essential for neuronal function, and its dysregulation has been implicated in neurodegenerative disorders. In particular, reduced intracellular copper levels alongside with elevated extracellular copper concentrations have been associated with Alzheimer’s disease (AD). Therefore, strategies aimed at restoring intracellular copper levels represent a potential therapeutic approach. In this study, we investigated the effects of selected copper-binding compounds─α-lipoic acid (LA), elesclomol (ES), disulfiram (DSF), thiourea (TU), and triapine (3-AP)─on copper uptake and cytotoxicity in SH-SY5Y wild-type (WT) and CTR1-deficient (CTR1–/–) cells. Intracellular copper levels were quantified using inductively coupled plasma mass spectrometry (ICP-MS), and cell viability was assessed by using propidium iodide assay under various treatment conditions. Among the tested compounds, LA, ES, and DSF significantly increased intracellular copper levels in both WT and CTR1–/– cells, whereas TU and 3-AP did not enhance copper accumulation beyond copper-only treatment. Notably, CTR1–/– cells exhibited reduced sensitivity to copper-associated toxicity compared to WT cells. Under copper-supplemented conditions, DSF and ES displayed concentration-dependent cytotoxicity, while LA and TU induced only mild effects. In contrast, 3-AP toxicity was abolished in the presence of copper. Furthermore, cotreatment with LA and copper increased cell proliferation and promoted differentiation-associated morphological changes in CTR1–/– cells. Overall, our results demonstrate that copper ionophores can enhance intracellular copper levels dependently and independently of CTR1, with distinct effects on cell viability. Among the tested compounds, LA and DSF showed a favorable profile by increasing copper levels while maintaining low cytotoxicity, highlighting their potential for modulating cellular copper homeostasis.Keywords
Funding Information
- Eesti Teadusagentuur (PRG1289)
This publication has 28 references indexed in Scilit:
- Disruption of Copper Redox Balance and Dysfunction under In Vivo and In Vitro Alzheimer’s Disease ModelsEnvironment & Health, 2024
- Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7AMolecular Oncology, 2021
- The combination of disulfiram and copper for cancer treatmentDrug Discovery Today, 2020
- Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agentScientific Reports, 2018
- Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexesBiochemical Pharmacology, 2014
- Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): A combined experimental and theoretical studyJournal of Inorganic Biochemistry, 2011
- Affinity gradients drive copper to cellular destinationsNature, 2010
- Alpha-lipoic acid differently affects the reserpine-induced oxidative stress in the striatum and prefrontal cortex of rat brainNeuroscience, 2007
- Thiourea protects against copper-induced oxidative damage by formation of a redox-inactive thiourea-copper complexFree Radical Biology and Medicine, 2002
- Structural chemistry of natural and synthetic inoophores and their complexes with cations1982